1. Arda D. Yalçınkaya, Günhan Dündar, Hamdi Torun
Glakolens A.Ş.
Bogazici University Medical Devices Spin-off

2. Glakolens AŞ, a spin-off startup built on research on micro-electro-mechanical systems (MEMS) and metamaterials at Boğaziçi University
Develops contact lens based novel biosensor technologies for the diagnosis and monitoring of glaucoma and other diseases
Early lab proof of concept prototypes are characterized, demonstrated, patented, and partially published
All IP rights of the technology are licensed by TTO of Boğaziçi University to Glakolens.
Secured over EUR 1.5mn investment and grants

3. Founders Günhan Dündar Hamdi Torun Arda Deniz Yalçınkaya
B.S., Electrical Eng., Bogazici Univ, 1989
M.S., Electrical Eng., Bogazici Univ, 1991
Ph.D., Electrical Eng., Rensselaer Polytechnic Institute, 1993
Prof. Dr., Electrical Eng., Bogazici Univ.,
EPFL, Tech. Univ. Munich Sabbatical Leave 2003 and 2010
BAP Research Award, 1996
BÜVAK Research Award, 2002
TÜBİTAK Outstanding Research Award, 2009.
Hamdi Torun
B.S., Electrical Eng., METU, 2003
M.S., Electrical Eng., Koc Univ., 2005
Ph.D., Electrical Eng., Georgia Tech, 2009
Postdoc ,Mechanical Eng., Georgia Tech,
Asst. Prof., Electrical Eng., Bogazici Univ., 2011-now
FP7 MC IRG Fellow,
Innovator Under 35 Award, MIT Tech Review, 2014
Arda Deniz Yalçınkaya
B.S., Electrical Eng., ITU, 1997
M.S., Electrical Eng., Tech. Univ. Denmark, 1999
Ph.D., Electrical Eng., Tech. Univ. Denmark, 2003
Postdoc, Electrical Eng., Koc Univ.,
Assoc. Prof., Electrical Eng., Bogazici Univ., 2006-now
BÜVAK Outstanding Research Award, 2010
METU Parlar Foundation, Research Award, 2011
Turkish Academy od Sciences, Young Researcher Award, 2013

4. Glakolens A.Ş.
Technology: A wireless, contact lens embedded sensor, with its peripheral eletronics and signal processing, to be used in glaucoma diagnosis and monitoring
IP: Two global applications for sensor platform and glaucoma sensing
Company structure:
Location: Bogazici University Technopark, A US office soon
Founders/Inventors: G. Dündar, A.D. Yalçınkaya, H. Torun
Technical consultant: Khalid. Mentak
Seed Investor: ACT-VC
Commercialisation Support: Boğaziçi University Technology Transfer Office
Team: a team of 8, including R&D engineers, technician, advisors

5. Glaucoma Chronic disease with no cure
€5bn Market, 70M people worldwide
The 2nd leading cause of blindness globally
No viable product in the market to continuously and wirelessly measure IoP

6. Technology Intra-Ocular-Pressure sensing with a Wireless
Bio-compatible
Non-invasive
Cost-effective
Contact lens embedded device
Data recorded and processed remotely
Patents pending
Lab proof of concept prototypes demonstrated

7. Plan
Financial Plan:
Glakolens has secured over 1.5 M Euro funding and grants for the development of an fully functional prototype
Development Timeline:
A solid business model, with key performance indicators
~18 months to realize a fully functional IOP monitoring sensor and its first generation read out system
Outlook:
A Series-A investment will be seeked following the next 18 months to conduct clinical trials and obtain regulatory approvals